Company intelligence / Profile preview

Wound Care Innovations

Fort Lauderdale, Florida, United States

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Wound Care Innovations developed and marketed CellerateRX, a hydrolyzed collagen-based wound care product, with evidence of clinical utility in treating skin tears, especially in elderly populations. Clinical results include positive clinician feedback and ongoing evidence-based studies, with the product already in commercial distribution.

Therapeutic areas: Dermatology
Modalities: Hydrolyzed collagenDevice
Industry: Therapeutic Medical Devices

Partnerships

Sanara MedTech (involved in further development/distribution of CellerateRX)

Beyond the preview

Go deeper on Wound Care Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wound Care Innovations.

Explore the full profile